Incidental Mutation 'R0030:Mmp23'
| ID |
15362 |
| Institutional Source |
Beutler Lab
|
| Gene Symbol |
Mmp23
|
| Ensembl Gene |
ENSMUSG00000029061 |
| Gene Name |
matrix metallopeptidase 23 |
| Synonyms |
CA-MMP, cysteine array matrix metalloproteinase |
| MMRRC Submission |
038324-MU
|
| Accession Numbers |
|
| Essential gene? |
Non essential
(E-score: 0.000)
|
| Stock # |
R0030 (G1)
|
| Quality Score |
|
|
Status
|
Validated
|
| Chromosome |
4 |
| Chromosomal Location |
155735112-155737841 bp(-) (GRCm39) |
| Type of Mutation |
nonsense |
| DNA Base Change (assembly) |
G to A
at 155735768 bp (GRCm39)
|
| Zygosity |
Heterozygous |
| Amino Acid Change |
Arginine to Stop codon
at position 268
(R268*)
|
| Ref Sequence |
ENSEMBL: ENSMUSP00000030937
(fasta)
|
| Gene Model |
predicted gene model for transcript(s):
[ENSMUST00000030937]
[ENSMUST00000067081]
[ENSMUST00000103176]
[ENSMUST00000105598]
[ENSMUST00000105600]
|
| AlphaFold |
O88676 |
| Predicted Effect |
probably null
Transcript: ENSMUST00000030937
AA Change: R268*
|
| SMART Domains |
Protein: ENSMUSP00000030937
Gene: ENSMUSG00000029061
AA Change: R268*
| Domain | Start | End | E-Value | Type |
|---|
|
low complexity region
|
19 |
41 |
N/A |
INTRINSIC |
|
ZnMc
|
85 |
256 |
8.39e-48 |
SMART |
|
ShKT
|
255 |
291 |
4.06e-10 |
SMART |
|
IG
|
307 |
390 |
4.53e-2 |
SMART |
|
| Predicted Effect |
probably benign
Transcript: ENSMUST00000067081
|
| SMART Domains |
Protein: ENSMUSP00000070527
Gene: ENSMUSG00000029062
| Domain | Start | End | E-Value | Type |
|---|
|
low complexity region
|
19 |
48 |
N/A |
INTRINSIC |
|
low complexity region
|
93 |
112 |
N/A |
INTRINSIC |
|
coiled coil region
|
123 |
214 |
N/A |
INTRINSIC |
|
low complexity region
|
252 |
259 |
N/A |
INTRINSIC |
|
low complexity region
|
261 |
272 |
N/A |
INTRINSIC |
|
coiled coil region
|
290 |
337 |
N/A |
INTRINSIC |
|
low complexity region
|
369 |
383 |
N/A |
INTRINSIC |
|
S_TKc
|
427 |
712 |
5.05e-93 |
SMART |
|
| Predicted Effect |
probably benign
Transcript: ENSMUST00000103176
|
| SMART Domains |
Protein: ENSMUSP00000099465
Gene: ENSMUSG00000029060
| Domain | Start | End | E-Value | Type |
|---|
|
Pfam:MIB_HERC2
|
12 |
78 |
3.4e-26 |
PFAM |
|
ZnF_ZZ
|
85 |
130 |
6.44e-9 |
SMART |
|
Pfam:MIB_HERC2
|
160 |
225 |
4.2e-26 |
PFAM |
|
Blast:ANK
|
285 |
320 |
2e-13 |
BLAST |
|
ANK
|
428 |
457 |
8.52e-4 |
SMART |
|
ANK
|
461 |
490 |
6.71e-2 |
SMART |
|
ANK
|
494 |
523 |
9.93e-5 |
SMART |
|
ANK
|
527 |
559 |
1.1e2 |
SMART |
|
ANK
|
563 |
593 |
9.21e0 |
SMART |
|
ANK
|
597 |
627 |
3.57e-6 |
SMART |
|
ANK
|
631 |
660 |
3.31e-1 |
SMART |
|
ANK
|
664 |
709 |
1.73e3 |
SMART |
|
Blast:ANK
|
733 |
762 |
9e-10 |
BLAST |
|
low complexity region
|
763 |
772 |
N/A |
INTRINSIC |
|
RING
|
798 |
832 |
2.55e-1 |
SMART |
|
RING
|
877 |
909 |
1.81e-2 |
SMART |
|
| Predicted Effect |
probably benign
Transcript: ENSMUST00000105598
|
| SMART Domains |
Protein: ENSMUSP00000101223
Gene: ENSMUSG00000029062
| Domain | Start | End | E-Value | Type |
|---|
|
low complexity region
|
2 |
13 |
N/A |
INTRINSIC |
|
low complexity region
|
59 |
78 |
N/A |
INTRINSIC |
|
coiled coil region
|
89 |
180 |
N/A |
INTRINSIC |
|
low complexity region
|
218 |
225 |
N/A |
INTRINSIC |
|
low complexity region
|
227 |
238 |
N/A |
INTRINSIC |
|
coiled coil region
|
256 |
303 |
N/A |
INTRINSIC |
|
low complexity region
|
335 |
349 |
N/A |
INTRINSIC |
|
S_TKc
|
393 |
678 |
5.05e-93 |
SMART |
|
| Predicted Effect |
probably benign
Transcript: ENSMUST00000105600
|
| SMART Domains |
Protein: ENSMUSP00000101225
Gene: ENSMUSG00000029062
| Domain | Start | End | E-Value | Type |
|---|
|
low complexity region
|
19 |
48 |
N/A |
INTRINSIC |
|
low complexity region
|
93 |
112 |
N/A |
INTRINSIC |
|
coiled coil region
|
123 |
214 |
N/A |
INTRINSIC |
|
low complexity region
|
252 |
259 |
N/A |
INTRINSIC |
|
low complexity region
|
261 |
272 |
N/A |
INTRINSIC |
|
coiled coil region
|
290 |
337 |
N/A |
INTRINSIC |
|
low complexity region
|
369 |
383 |
N/A |
INTRINSIC |
|
S_TKc
|
427 |
712 |
5.05e-93 |
SMART |
|
| Predicted Effect |
noncoding transcript
Transcript: ENSMUST00000128204
|
| Predicted Effect |
noncoding transcript
Transcript: ENSMUST00000130944
|
| Predicted Effect |
noncoding transcript
Transcript: ENSMUST00000143196
|
| Predicted Effect |
noncoding transcript
Transcript: ENSMUST00000139788
|
| Predicted Effect |
noncoding transcript
Transcript: ENSMUST00000155100
|
| Predicted Effect |
noncoding transcript
Transcript: ENSMUST00000139242
|
| Predicted Effect |
noncoding transcript
Transcript: ENSMUST00000156906
|
| Predicted Effect |
noncoding transcript
Transcript: ENSMUST00000139134
|
| Predicted Effect |
noncoding transcript
Transcript: ENSMUST00000151843
|
| Meta Mutation Damage Score |
0.9755 |
| Coding Region Coverage |
- 1x: 78.5%
- 3x: 68.6%
- 10x: 42.5%
- 20x: 22.6%
|
| Validation Efficiency |
97% (72/74) |
| MGI Phenotype |
FUNCTION: This gene encodes a member of the matrix metalloproteinase family of extracellular matrix-degrading enzymes that are involved in tissue remodeling, wound repair, progression of atherosclerosis and tumor invasion. The encoded protein contains an N-terminal cysteine array and a novel immunoglobulin-fold domain at the C-terminus. Alternative splicing results in multiple transcript variants encoding different isoforms that may undergo similar processing. [provided by RefSeq, Feb 2016]
|
| Allele List at MGI |
All alleles(5) : Targeted(2) Gene trapped(3)
|
| Other mutations in this stock |
Total: 30 list
| Gene | Ref | Var | Chr/Loc | Mutation | Predicted Effect | Zygosity |
|---|
| Aebp2 |
A |
C |
6: 140,583,473 (GRCm39) |
S316R |
probably damaging |
Het |
| Brwd1 |
A |
G |
16: 95,822,456 (GRCm39) |
S1250P |
probably damaging |
Het |
| Cacna1s |
T |
C |
1: 136,022,727 (GRCm39) |
|
probably null |
Het |
| Cass4 |
G |
T |
2: 172,269,762 (GRCm39) |
E617* |
probably null |
Het |
| Cct4 |
T |
C |
11: 22,951,357 (GRCm39) |
|
probably benign |
Het |
| Cdh20 |
C |
T |
1: 110,065,798 (GRCm39) |
Q691* |
probably null |
Het |
| Crip1 |
G |
A |
12: 113,116,996 (GRCm39) |
|
probably null |
Het |
| Dnah5 |
A |
T |
15: 28,451,663 (GRCm39) |
D4367V |
probably benign |
Het |
| Dock3 |
A |
G |
9: 106,789,512 (GRCm39) |
V1514A |
possibly damaging |
Het |
| Eps15l1 |
A |
G |
8: 73,126,894 (GRCm39) |
S646P |
probably benign |
Het |
| Faap24 |
A |
T |
7: 35,092,285 (GRCm39) |
F211I |
probably damaging |
Het |
| Flrt3 |
A |
T |
2: 140,502,237 (GRCm39) |
Y464N |
probably damaging |
Het |
| Foxi2 |
A |
G |
7: 135,013,345 (GRCm39) |
T192A |
probably damaging |
Het |
| Gm7298 |
T |
A |
6: 121,751,009 (GRCm39) |
F695L |
probably benign |
Het |
| Ifnk |
T |
G |
4: 35,152,489 (GRCm39) |
V139G |
probably benign |
Het |
| Kif18a |
A |
T |
2: 109,163,663 (GRCm39) |
I671L |
probably benign |
Het |
| Lcn10 |
T |
C |
2: 25,575,093 (GRCm39) |
F154L |
probably damaging |
Het |
| Med12l |
T |
G |
3: 59,156,076 (GRCm39) |
L1198R |
probably damaging |
Het |
| Mrps30 |
T |
C |
13: 118,519,531 (GRCm39) |
D298G |
possibly damaging |
Het |
| Myh7 |
T |
A |
14: 55,229,427 (GRCm39) |
T124S |
probably benign |
Het |
| Odf4 |
T |
A |
11: 68,817,767 (GRCm39) |
E9D |
probably benign |
Het |
| Ptchd4 |
T |
A |
17: 42,627,999 (GRCm39) |
C153* |
probably null |
Het |
| Scp2 |
T |
A |
4: 107,964,887 (GRCm39) |
|
probably null |
Het |
| Slc16a10 |
A |
G |
10: 39,952,819 (GRCm39) |
V225A |
probably benign |
Het |
| Slc66a1 |
A |
G |
4: 139,033,764 (GRCm39) |
S52P |
probably damaging |
Het |
| Tbk1 |
A |
G |
10: 121,397,529 (GRCm39) |
V381A |
probably benign |
Het |
| Tdrd6 |
T |
C |
17: 43,937,482 (GRCm39) |
K1189E |
possibly damaging |
Het |
| Ttc39a |
C |
A |
4: 109,280,170 (GRCm39) |
H151N |
probably benign |
Het |
| Ush2a |
C |
T |
1: 188,554,854 (GRCm39) |
T3544M |
possibly damaging |
Het |
| Vnn1 |
A |
G |
10: 23,776,744 (GRCm39) |
H365R |
probably benign |
Het |
|
| Other mutations in Mmp23 |
| Allele | Source | Chr | Coord | Type | Predicted Effect | PPH Score |
|---|
|
IGL00777:Mmp23
|
APN |
4 |
155,735,464 (GRCm39) |
missense |
possibly damaging |
0.67 |
|
IGL02749:Mmp23
|
APN |
4 |
155,735,989 (GRCm39) |
missense |
possibly damaging |
0.65 |
|
R0173:Mmp23
|
UTSW |
4 |
155,735,222 (GRCm39) |
missense |
possibly damaging |
0.82 |
|
R0244:Mmp23
|
UTSW |
4 |
155,736,589 (GRCm39) |
missense |
probably damaging |
1.00 |
|
R1521:Mmp23
|
UTSW |
4 |
155,735,174 (GRCm39) |
missense |
possibly damaging |
0.92 |
|
R1696:Mmp23
|
UTSW |
4 |
155,735,166 (GRCm39) |
makesense |
probably null |
|
|
R1957:Mmp23
|
UTSW |
4 |
155,736,509 (GRCm39) |
missense |
possibly damaging |
0.96 |
|
R2055:Mmp23
|
UTSW |
4 |
155,736,444 (GRCm39) |
missense |
possibly damaging |
0.76 |
|
R3946:Mmp23
|
UTSW |
4 |
155,736,480 (GRCm39) |
missense |
probably damaging |
1.00 |
|
R4170:Mmp23
|
UTSW |
4 |
155,735,767 (GRCm39) |
missense |
probably damaging |
0.99 |
|
R5153:Mmp23
|
UTSW |
4 |
155,735,797 (GRCm39) |
missense |
probably damaging |
1.00 |
|
R5660:Mmp23
|
UTSW |
4 |
155,735,710 (GRCm39) |
missense |
probably damaging |
1.00 |
|
R6193:Mmp23
|
UTSW |
4 |
155,735,990 (GRCm39) |
missense |
possibly damaging |
0.90 |
|
R6480:Mmp23
|
UTSW |
4 |
155,736,798 (GRCm39) |
missense |
probably damaging |
1.00 |
|
R7426:Mmp23
|
UTSW |
4 |
155,736,041 (GRCm39) |
missense |
probably damaging |
1.00 |
|
R7979:Mmp23
|
UTSW |
4 |
155,736,462 (GRCm39) |
missense |
possibly damaging |
0.90 |
|
R9500:Mmp23
|
UTSW |
4 |
155,736,567 (GRCm39) |
missense |
probably benign |
0.17 |
|
R9545:Mmp23
|
UTSW |
4 |
155,735,980 (GRCm39) |
missense |
probably benign |
0.00 |
|
R9757:Mmp23
|
UTSW |
4 |
155,735,515 (GRCm39) |
missense |
probably damaging |
1.00 |
|
| Protein Function and Prediction |
MMP23 is a member of the MMP superfamily of proteases that are zinc-dependent endopeptidases that function in degrading exracellular matrix proteins (1-4). MMP23 is a membrane-anchored type II glycoprotein (3;4). MMP23 does not share the typical structural features of MMPs (e.g., MMP23 has a unique transmembrane domain to other membrane-bound MMPs, MMP23 does not have specific residues close to the zinc-binding site, and it does not have a fibronectin-like domain) (1;2). MMP23 is proposed to function in cartilage and bone formation (5) as well as in tissue remodeling in reproductive tissues under physiological conditions (1).
|
| Expression/Localization |
MMP23 is expressed in the amniochorion during preterm premature rupture of membranes (pPROM) (6) as well as in the ovary, testis, and prostate (1;4). Mmp23 is also expressed in chondrocytes and osteoblasts (5).
|
| References |
1. Velasco, G., Pendas, A. M., Fueyo, A., Knauper, V., Murphy, G., and Lopez-Otin, C. (1999) Cloning and Characterization of Human MMP-23, a New Matrix Metalloproteinase Predominantly Expressed in Reproductive Tissues and Lacking Conserved Domains in Other Family Members. J Biol Chem. 274, 4570-4576.
4. Ohnishi, J., Ohnishi, E., Jin, M., Hirano, W., Nakane, D., Matsui, H., Kimura, A., Sawa, H., Nakayama, K., Shibuya, H., Nagashima, K., and Takahashi, T. (2001) Cloning and Characterization of a Rat Ortholog of MMP-23 (Matrix Metalloproteinase-23), a Unique Type of Membrane-Anchored Matrix Metalloproteinase and Conditioned Switching of its Expression during the Ovarian Follicular Development. Mol Endocrinol. 15, 747-764.
5. Clancy, B. M., Johnson, J. D., Lambert, A. J., Rezvankhah, S., Wong, A., Resmini, C., Feldman, J. L., Leppanen, S., and Pittman, D. D. (2003) A Gene Expression Profile for Endochondral Bone Formation: Oligonucleotide Microarrays Establish Novel Connections between Known Genes and BMP-2-Induced Bone Formation in Mouse Quadriceps. Bone. 33, 46-63. |
| Posted On |
2012-12-17 |
| Science Writer |
Anne Murray |
Incidental Mutation